Literature DB >> 11095777

Immunization for Prevention of Infective Endocarditis.

.   

Abstract

Immunization has been used for many years to prevent certain infectious diseases. Often it is targeted to populations at increased risk of a particular infection. Patients at increased risk of infective endocarditis can be identified and would be eligible candidates for immunization if vaccines were available to prevent common bacterial causes of infective endocarditis. The idea of using preventive therapy among patients at increased risk of infective endocarditis is not novel, and recommendations for use of antibiotics prior to performing certain invasive procedures have been in place for years. Findings from immunization experiments using animal models of experimental endocarditis support the notion that vaccine development is appropriate for study in humans, and these findings are reviewed in this paper.

Entities:  

Year:  1999        PMID: 11095777     DOI: 10.1007/s11908-996-0018-4

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  10 in total

1.  Protective efficacy of antibodies to the Staphylococcus aureus type 5 capsular polysaccharide in a modified model of endocarditis in rats.

Authors:  J C Lee; J S Park; S E Shepherd; V Carey; A Fattom
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

2.  Immunization with FimA protects against Streptococcus parasanguis endocarditis in rats.

Authors:  H B Viscount; C L Munro; D Burnette-Curley; D L Peterson; F L Macrina
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

Review 3.  Prevention of bacterial endocarditis. Recommendations by the American Heart Association.

Authors:  A S Dajani; K A Taubert; W Wilson; A F Bolger; A Bayer; P Ferrieri; M H Gewitz; S T Shulman; S Nouri; J W Newburger; C Hutto; T J Pallasch; T W Gage; M E Levison; G Peter; G Zuccaro
Journal:  Circulation       Date:  1997-07-01       Impact factor: 29.690

4.  Autoinducer of virulence as a target for vaccine and therapy against Staphylococcus aureus.

Authors:  N Balaban; T Goldkorn; R T Nhan; L B Dang; S Scott; R M Ridgley; A Rasooly; S C Wright; J W Larrick; R Rasooly; J R Carlson
Journal:  Science       Date:  1998-04-17       Impact factor: 47.728

5.  FimA, a major virulence factor associated with Streptococcus parasanguis endocarditis.

Authors:  D Burnette-Curley; V Wells; H Viscount; C L Munro; J C Fenno; P Fives-Taylor; F L Macrina
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

Review 6.  Pathogenesis of experimental endocarditis.

Authors:  L M Baddour; G D Christensen; J H Lowrance; W A Simpson
Journal:  Rev Infect Dis       Date:  1989 May-Jun

7.  Immunization with fibronectin binding protein from Staphylococcus aureus protects against experimental endocarditis in rats.

Authors:  T Schennings; A Heimdahl; K Coster; J I Flock
Journal:  Microb Pathog       Date:  1993-09       Impact factor: 3.738

8.  Protection against endocarditis due to Staphylococcus epidermidis by immunization with capsular polysaccharide/adhesin.

Authors:  S Takeda; G B Pier; Y Kojima; M Tojo; E Muller; T Tosteson; D A Goldmann
Journal:  Circulation       Date:  1991-12       Impact factor: 29.690

Review 9.  Infective endocarditis complicating mitral valve prolapse: epidemiologic, clinical, and microbiologic aspects.

Authors:  L M Baddour; A L Bisno
Journal:  Rev Infect Dis       Date:  1986 Jan-Feb

10.  Antibodies to capsular polysaccharides are not protective against experimental Staphylococcus aureus endocarditis.

Authors:  J Nemeth; J C Lee
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

  10 in total
  1 in total

1.  The sloABCR operon of Streptococcus mutans encodes an Mn and Fe transport system required for endocarditis virulence and its Mn-dependent repressor.

Authors:  Sehmi Paik; Arunsri Brown; Cindy L Munro; Cynthia Nau Cornelissen; Todd Kitten
Journal:  J Bacteriol       Date:  2003-10       Impact factor: 3.490

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.